EGF and neoplasm: In vivo experiments on tumor-bearing mice proved that locoregional injection of MNTC-EGF conjugated with 111In resulted in significant tumor growth inhibition compared to tumor-bearing animals receiving a corresponding dose of non-labeled MNT or free 111In (Rosenkranz et al., 2018).